Galapagos reported EUR780K in Interest Expense on Debt for its fiscal quarter ending in March of 2025.


Interest Expense On Debt Change Date
argenx SE 1.13M 9K Jun/2025
AstraZeneca 303M 126M Jun/2025
Biogen USD 72.6M 12.6M Jun/2025
Genmab DKK 9M 4M Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
GlaxoSmithKline 184M 22M Jun/2025
GRIFOLS EUR 202.71M 94.07M Jun/2024
Hikma Pharmaceutical 22M 9M Jun/2024
Incyte USD 594K 66K Jun/2025
Merck 79M 1000K Jun/2025
Neurocrine Biosciences USD 1.1M 0 Mar/2024
Novartis USD 289M 19M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sanofi 148M 65M Jun/2025
UCB 108M 16M Dec/2024
Vertex Pharmaceuticals USD 3.7M 900K Jun/2025